The Italian LGMD registry reported the CAPN3 gene as the leading cause, with DYSF and sarcoglycanopathies also frequently represented, reflecting a distribution pattern comparable to other European countries [16]. This evidence concerns the gene CAPN3 and limb-girdle muscular dystrophy.